L3VLUP
ProSign in

LNTH · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LNTHVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LNTH
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterLNTHVRTX
Q3 20201 holders, $34m31 holders, $21.9bn
Q4 20201 holders, $36m30 holders, $18.4bn
Q1 20212 holders, $71m31 holders, $15.4bn
Q2 20213 holders, $71m30 holders, $12.7bn
Q3 20212 holders, $57m35 holders, $10.1bn
Q4 20212 holders, $64m28 holders, $12.4bn
Q1 20228 holders, $299m23 holders, $16.1bn
Q2 20229 holders, $313m25 holders, $18.1bn
Q3 20229 holders, $357m22 holders, $18.4bn
Q4 202212 holders, $312m28 holders, $18.4bn
Q1 202316 holders, $723m26 holders, $21.4bn
Q2 202318 holders, $897m27 holders, $24.7bn
Q3 20239 holders, $628m33 holders, $24.3bn
Q4 20238 holders, $470m32 holders, $28.6bn
Q1 20249 holders, $431m31 holders, $29.8bn
Q2 20248 holders, $577m29 holders, $33.4bn
Q3 20247 holders, $830m27 holders, $33.5bn
Q4 20247 holders, $1.1bn26 holders, $28.5bn
Q1 20255 holders, $1.3bn21 holders, $35.4bn
Q2 20259 holders, $1.4bn21 holders, $32.3bn
Q3 20258 holders, $572m22 holders, $25.9bn
Q4 20256 holders, $862m26 holders, $31.8bn
Q1 20266 holders, $963m25 holders, $31.8bn
Q2 202610 holders, $1.6bn26 holders, $34.6bn
LNTH

Lantheus HLDGS Inc

Holders
6
Reported value
$862m
Buyers
13
Sellers
20

Breadth -7 among 92 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUP
VRTX

Vertex Pharmaceuticals Inc

Holders
26
Reported value
$31.8bn
Buyers
19
Sellers
20

Breadth -1 among 92 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2025

Among the 30 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LNTH (4)

Farallon Capital Management LLC, Freestone Grove Partners LP, Moore Capital Management LP, Point72 Asset Management LP

Only VRTX (24)

Acadian Asset Management LLC, AllianceBernstein LP, ARK Investment Management LLC, Arrowstreet Capital LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →